Gene therapy: A brief overview of the past, present, and future

Annals of the New York Academy of Sciences

Volumn 953, Issue , 2001, Pages 26-30

  Scollay, Roland ^a  

^a Genteric Corporation   (United States)

Author keywords

Cancer; Cardiovascular disease; Clinical trials; Gene therapy; Hemophilia; Trial design

Indexed keywords

CANCER; CARDIOVASCULAR DISEASE; COMMERCIAL PHENOMENA; CONFERENCE PAPER; GENE DELIVERY SYSTEM; GENE THERAPY; GEOGRAPHIC DISTRIBUTION; HEART DISEASE; HUMAN; MEDICAL ETHICS; PUBLIC HEALTH;

EID: 0035690084     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb11357.x     Document Type: Conference Paper

References (8)

1. An early history of gene transfer and therapy
2. T-lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years
3. Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for tumor necrosis factor
4. Evidence for gene transfer and expression of factor IX in hemophilia patients treated with an AAV vector
5. Gene therapy of severe combined immunodeficiency (SCID)-X1 disease
6. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer